BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 15477430)

  • 1. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
    Waselenko JK; Nace MC; Alving B
    Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hormonal changes in women on hemostasis].
    Malý J; Dulícek P
    Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago)
    Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism during hormone therapy in Japanese women.
    Adachi T; Sakamoto S
    Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex and gender issues and venous thromboembolism.
    Moores L; Bilello KL; Murin S
    Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.